Jason B. Garrison, Ph.D. - Publications
Affiliations: | 2007 | University of Kentucky, Lexington, KY |
Area:
BiochemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Garrison JB, Ge C, Che L, Pullum DA, Peng G, Khan S, Ben-Jonathan N, Wang J, Du C. Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents. Journal of Cancer Science & Therapy. 7: 121-126. PMID 26191375 DOI: 10.4172/1948-5956.1000335 | 0.331 | |||
2007 | Garrison JB, Shaw YJ, Chen CS, Kyprianou N. Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity. Cancer Research. 67: 11344-52. PMID 18056461 DOI: 10.1158/0008-5472.Can-07-1662 | 0.627 | |||
2006 | Isaacs JT, Pili R, Qian DZ, Dalrymple SL, Garrison JB, Kyprianou N, Björk A, Olsson A, Leanderson T. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer. The Prostate. 66: 1768-78. PMID 16955399 DOI: 10.1002/Pros.20509 | 0.573 | |||
2006 | Garrison JB, Kyprianou N. Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cancer Research. 66: 464-72. PMID 16397262 DOI: 10.1158/0008-5472.Can-05-2039 | 0.603 | |||
2005 | Keledjian K, Garrison JB, Kyprianou N. Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion. Journal of Cellular Biochemistry. 94: 374-88. PMID 15526277 DOI: 10.1002/Jcb.20240 | 0.566 | |||
2004 | Shaw YJ, Yang YT, Garrison JB, Kyprianou N, Chen CS. Pharmacological exploitation of the alpha1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation. Journal of Medicinal Chemistry. 47: 4453-62. PMID 15317457 DOI: 10.1021/Jm049752K | 0.608 | |||
2004 | Garrison JB, Kyprianou N. Novel targeting of apoptosis pathways for prostate cancer therapy. Current Cancer Drug Targets. 4: 85-95. PMID 14965270 DOI: 10.2174/1568009043481623 | 0.641 | |||
Show low-probability matches. |